The development course of Shanghai Hyundai Pharmaceutical Co., Ltd..

1996 Shanghai Hyundai Pharmaceutical Co., Ltd. was established in 2000. Shanghai Hyundai Pharmaceutical Co., Ltd. was established in 2004, and Hyundai Pharmaceutical A shares (600420) were listed on the Shanghai Stock Exchange. In 2008, Shanghai Hyundai Hasen Pharmaceutical Co., Ltd. was acquired (wholly-owned acquisition was renamed). In 2009, Shanghai Hyundai Pharmaceutical Haimen Co., Ltd. (raw material drug production base) was established, joined Sinopharm Group in 20 10, became a subsidiary of China Pharmaceutical Industry Research Institute in 20 10, and held a shareholders' meeting in 2010; Hyundai Hassan will invest in the construction of the national basic drug production base, and the office address will be moved to Beijing West Road12/320; Acquisition of Rong Sheng Pharmaceutical; Xin Ran's sales revenue broke 200 million.